Procoagulant cytokines, including interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF)-a, promote the upregulation of tissue factor (TF) and cancer procoagulant (CP) expression [4], amplifying thrombotic risk. The gene discussed is CP; the disease is cancer.